New hope for tough cancer: testing a powerful drug cocktail
NCT ID NCT07348107
Summary
This early-stage study aims to find out if adding three new drugs to standard chemotherapy is safe for people with advanced pancreatic cancer that has spread or cannot be removed by surgery. Up to 10 participants will receive the combination treatment, which includes an immunotherapy drug and two other medications that may help the body fight cancer. The main goal is to check for side effects, but researchers will also see if the treatment might help people live longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Verspeeten Family Cancer Centre
London, Ontario, N6A 5W9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.